Delivery Order SPE2DB20D1051-SPE2DB25FD6PD
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,029.44 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 4,564,751,037 units of Candesartan Cilexetil 16 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The...
This contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $1,635.26. The award is for the supply of 4,566,467,914 units of Candesartan Cilexetil 32 mg tablets. This contract does not have a set-aside designation, indicating an open competition. The DLA Troop Support Medical IDC, valued at $999,999,999, serves as a primary vehicle for...
This federal contract award, valued at $17,820.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,712,428 units of Candesartan Cilexetil 32 mg tablets in 90-count bottles.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is a delivery order with a firm fixed price of $9,890.36 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,565,404,314 units of Candesartan Cilexetil 16 MG tablets, which are likely a critical pharmaceutical product used by the U.S. military and other federal healthcare programs. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price ceiling value of $9,059.79 and a period of performance extending to October 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,575.64 firm fixed-price delivery order contract is for the supply of Candesartan Cilexetil 16 mg Tablets, a cardiovascular medication, to support military healthcare programs. The contract has a period of performance through January 3, 2025.
Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,085.50 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 32 mg tablets, with a completion date of November 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,885,666 units of the drug Candesartan Cilexetil 8 mg Tablets. The contract has a ceiling value of $2,572.11 and a completion date of June 13, 2024. It is a firm fixed-price delivery order and was not subject to any set-aside requirements.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide 4,566,271,119 units of the pharmaceutical drug Candesartan Cilexetil 32 mg. The delivery order has a firm fixed-price contract type, a ceiling value of $7,881.24, and a period of performance through October 31, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,008.48 Firm Fixed Price delivery order is for the supply of 90-count bottles of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of November 13, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop...